Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken.
Watch this short video to learn why!

Benchmark: FDA Proposed Rule: N-acetyl-L-cysteine (NAC) and the Dietary Supplement Definition

Take this benchmark to assess how much you would benefit from taking the course on the FDA’s proposed rule clarifying NAC’s status as a dietary supplement.

This quick check surfaces how well you grasp the rule’s intent, who it affects, and what would change operationally if finalized. Your responses help you decide whether to invest in the full course now, and which areas to prioritize.

  • Why it matters: The rule would remove uncertainty about NAC in supplements, shaping product strategy, labeling, and compliance.
  • What you’ll get: A sense of your readiness on policy intent, operational impact, equity and access, compliance risks, and opportunities to comment.
  • Who it’s for: Brands, retailers, regulatory/QA, legal, product, and clinicians who interact with NAC products.

Result: If you find the trade-offs and implications unclear, the course will provide structured guidance, examples, and next steps for compliance and stakeholder engagement.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.

Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition. Document Number: 2026-23351

Buy this Course
FR-26-3332-1

About Benchmarks:

Are you ready for this regulation? Use this benchmark to find out.

Each benchmark is build directly for the federal regulation.  They reflect the learning objectives of the related course.

The benchmark is not a “trivia test” – they help you evaluate your readiness to apply the new regulation.

Contact us for more information and/or personalized benchmarks for your specific organization/industry.

Benchmark: FDA Proposed Rule: N-acetyl-L-cysteine (NAC) and the Dietary Supplement Definition

Take this benchmark to assess how much you would benefit from taking the course on the FDA’s proposed rule clarifying NAC’s status as a dietary supplement.

This quick check surfaces how well you grasp the rule’s intent, who it affects, and what would change operationally if finalized. Your responses help you decide whether to invest in the full course now, and which areas to prioritize.

  • Why it matters: The rule would remove uncertainty about NAC in supplements, shaping product strategy, labeling, and compliance.
  • What you’ll get: A sense of your readiness on policy intent, operational impact, equity and access, compliance risks, and opportunities to comment.
  • Who it’s for: Brands, retailers, regulatory/QA, legal, product, and clinicians who interact with NAC products.

Result: If you find the trade-offs and implications unclear, the course will provide structured guidance, examples, and next steps for compliance and stakeholder engagement.

NOTE: Unless otherwise indicated, all Benchmarks are free of charge!

Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition. Document Number: 2026-23351

Buy this Course
FR-26-3332-1

Replenish your Studio Course Advisor Unit balance here . Please contact frsales@courseavenue.com if you need to purchase more. Talk to use about an Enterprise License to see if that is right for you!

Benchmark: FDA Proposed Rule: N-acetyl-L-cysteine (NAC) and the Dietary Supplement Definition

Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition. Document Number: 2026-23351

Buy this Course
FR-26-3332-1

Take this benchmark to assess how much you would benefit from taking the course on the FDA’s proposed rule clarifying NAC’s status as a dietary supplement.

This quick check surfaces how well you grasp the rule’s intent, who it affects, and what would change operationally if finalized. Your responses help you decide whether to invest in the full course now, and which areas to prioritize.

  • Why it matters: The rule would remove uncertainty about NAC in supplements, shaping product strategy, labeling, and compliance.
  • What you’ll get: A sense of your readiness on policy intent, operational impact, equity and access, compliance risks, and opportunities to comment.
  • Who it’s for: Brands, retailers, regulatory/QA, legal, product, and clinicians who interact with NAC products.

Result: If you find the trade-offs and implications unclear, the course will provide structured guidance, examples, and next steps for compliance and stakeholder engagement.

Related products